全文获取类型
收费全文 | 234969篇 |
免费 | 15306篇 |
国内免费 | 988篇 |
专业分类
耳鼻咽喉 | 2536篇 |
儿科学 | 5992篇 |
妇产科学 | 4431篇 |
基础医学 | 29320篇 |
口腔科学 | 4320篇 |
临床医学 | 24063篇 |
内科学 | 49592篇 |
皮肤病学 | 3229篇 |
神经病学 | 23674篇 |
特种医学 | 10115篇 |
外国民族医学 | 13篇 |
外科学 | 37099篇 |
综合类 | 2538篇 |
现状与发展 | 1篇 |
一般理论 | 177篇 |
预防医学 | 16525篇 |
眼科学 | 5529篇 |
药学 | 15510篇 |
1篇 | |
中国医学 | 324篇 |
肿瘤学 | 16274篇 |
出版年
2023年 | 1335篇 |
2022年 | 2190篇 |
2021年 | 5335篇 |
2020年 | 3043篇 |
2019年 | 5055篇 |
2018年 | 6054篇 |
2017年 | 4442篇 |
2016年 | 4855篇 |
2015年 | 5734篇 |
2014年 | 8355篇 |
2013年 | 11255篇 |
2012年 | 17284篇 |
2011年 | 18022篇 |
2010年 | 10076篇 |
2009年 | 9313篇 |
2008年 | 15870篇 |
2007年 | 16664篇 |
2006年 | 16205篇 |
2005年 | 16076篇 |
2004年 | 15111篇 |
2003年 | 13793篇 |
2002年 | 13192篇 |
2001年 | 1935篇 |
2000年 | 1446篇 |
1999年 | 2007篇 |
1998年 | 2784篇 |
1997年 | 2214篇 |
1996年 | 1924篇 |
1995年 | 1762篇 |
1994年 | 1526篇 |
1993年 | 1494篇 |
1992年 | 984篇 |
1991年 | 934篇 |
1990年 | 789篇 |
1989年 | 747篇 |
1988年 | 682篇 |
1987年 | 618篇 |
1986年 | 642篇 |
1985年 | 682篇 |
1984年 | 910篇 |
1983年 | 789篇 |
1982年 | 1036篇 |
1981年 | 968篇 |
1980年 | 841篇 |
1979年 | 468篇 |
1978年 | 518篇 |
1977年 | 447篇 |
1976年 | 419篇 |
1975年 | 316篇 |
1974年 | 310篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
191.
192.
Dnyanesh N Tipre Sami S Zoghbi Jeih-San Liow Michael V Green Jurgen Seidel Masanori Ichise Robert B Innis Victor W Pike 《Journal of nuclear medicine》2006,47(2):345-353
18F-FCWAY (18F-trans-4-fluoro-N-(2-[4-(2-methoxyphenyl) piperazin-1-yl)ethyl]-N-(2-pyridyl)cyclohexanecarboxamide) is useful in clinical research with PET for measuring serotonin 1A (5-HT1A) receptor densities in brain regions of human subjects but has significant bone uptake of radioactivity due to defluorination. The uptake of radioactivity in skull compromises the accuracy of measurements of 5-HT1A receptor densities in adjacent areas of brain because of spillover of radioactivity through the partial-volume effect. Our aim was to demonstrate with a rat model that defluorination of 18F-FCWAY may be inhibited in vivo to improve its applicability to measuring brain regional 5-HT1A receptor densities. METHODS: PET of rat head after administration of 18F-FCWAY was used to confirm that the distribution of radioactivity measured in brain is dominated by binding to 5-HT1A receptors and to reveal the extent of defluorination of 18F-FCWAY in vivo as represented by radioactivity (18F-fluoride ion) uptake in skull. Cimetidine, diclofenac, and miconazole, known inhibitors of CYP450 2EI, were tested for the ability to inhibit defluorination of 18F-FCWAY in rat liver microsomes in vitro. The effects of miconazole treatment of rats on skull radioactivity uptake and, in turn, its spillover on brain 5-HT1A receptor imaging were assessed by PET with venous blood analysis. RESULTS: PET confirmed the potential of 18F-FCWAY to act as a radioligand for 5-HT1A receptors in rat brain and also revealed extensive defluorination. In rat liver microsomes in vitro, defluorination of 18F-FCWAY was almost completely inhibited by miconazole and, to a less extent, by diclofenac. In PET experiments, treatment of rats with miconazole nitrate (60 mg/kg intravenously) over the 45-min period before administration of 18F-FCWAY almost obliterated defluorination and bone uptake of radioactivity. Also, brain radioactivity almost doubled while the ratio of radioactivity in receptor-rich ventral hippocampus to that in receptor-poor cerebellum almost tripled to 14. The plasma half-life of radioligand was also extended by miconazole treatment. CONCLUSION: Miconazole treatment, by eliminating defluorination of 18F-FCWAY, results in effective imaging of brain 5-HT1A receptors in rat. 18F-FCWAY PET in miconazole-treated rats can serve as an effective platform for investigating 5-HT1A receptors in rodent models of neuropsychiatric conditions or drug action. 相似文献
193.
194.
195.
Molecular determinants of cetuximab efficacy. 总被引:17,自引:0,他引:17
Daniel Vallb?hmer Wu Zhang Michael Gordon Dong Yun Yang Jim Yun Oliver A Press Katrin E Rhodes Andy E Sherrod Syma Iqbal Kathleen D Danenberg Susan Groshen Heinz-Josef Lenz 《Journal of clinical oncology》2005,23(15):3536-3544
PURPOSE: To investigate whether mRNA expression levels of cyclin D1 (CCND1), cyclooxygenase 2 (Cox-2), epidermal growth factor receptor (EGFR), interleukin 8 (IL-8), and vascular endothelial growth factor (VEGF), all members of the EGFR signaling pathway, are associated with clinical outcome in patients with EGFR-expressing metastatic colorectal cancer (CRC) treated with cetuximab. PATIENTS AND METHODS: Thirty-nine patients with metastatic CRC, refractory to both irinotecan and oxaliplatin, were enrolled on IMCL-0144 and treated with single-agent cetuximab. The intratumoral mRNA levels of CCND1, Cox-2, EGFR, IL-8, and VEGF were assessed from paraffin-embedded tissue samples using laser-capture microdissection and quantitative real-time polymerase chain reaction. RESULTS: There were 21 women and 18 men with a median age of 64 years (range, 35 to 83 years). Higher gene expression levels of VEGF were associated with resistance to cetuximab (P = .038; Kruskal-Wallis test). The combination of low gene expression levels of Cox-2, EGFR, and IL-8 was significantly associated with overall survival (13.5 v 2.3 months; P = .028; log-rank test). Both findings were independent of skin toxicity that was itself significantly correlated to survival. Patients with a lower mRNA amount of EGFR had a longer overall survival compared with patients that had a higher mRNA amount (7.3 v 2.2 months; P = .09; log-rank test). Patients with lower expression of Cox-2 had a significantly higher rate of grade 2 to 3 skin reactions under cetuximab treatment. CONCLUSION: This pilot study suggests that gene expression levels of Cox-2, EGFR, IL-8, and VEGF in patients with metastatic CRC may be useful markers of clinical outcome in single-agent cetuximab treatment. 相似文献
196.
197.
198.
199.
200.
Angelo Lipira David Limbrick Bruce Haughey Phillip Custer Michael R. Chicoine 《Skull base》2009,19(4):303-309